Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Galactose challenge tests |
Has measured component (attribute) |
False |
Galactose |
Inferred relationship |
Some |
|
Galactose renal clearance measurement |
Has measured component (attribute) |
False |
Galactose |
Inferred relationship |
Some |
|
Galactose measurement, urine |
Has measured component (attribute) |
False |
Galactose |
Inferred relationship |
Some |
|
Galactose measurement |
Has measured component (attribute) |
False |
Galactose |
Inferred relationship |
Some |
|
Galactose screening test for galactosemia |
Has measured component (attribute) |
False |
Galactose |
Inferred relationship |
Some |
|
Galactose challenge tests |
Component |
True |
Galactose |
Inferred relationship |
Some |
1 |
Galactose renal clearance measurement |
Component |
False |
Galactose |
Inferred relationship |
Some |
|
Galactose measurement, urine |
Component |
False |
Galactose |
Inferred relationship |
Some |
2 |
Galactose measurement |
Component |
True |
Galactose |
Inferred relationship |
Some |
1 |
Galactose screening test for galactosemia |
Component |
True |
Galactose |
Inferred relationship |
Some |
1 |
Product containing galactose microparticles |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Galactose |
Inferred relationship |
Some |
|
Galactose microparticles 3g granules+vehicle |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Galactose |
Inferred relationship |
Some |
|
Galactose microparticles 3996mg/palmitic acid 4mg powder and solvent for injection suspension vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Galactose |
Inferred relationship |
Some |
|
Galactose microparticles 2497.5mg/palmitic acid 2.5mg powder and solvent for injection suspension vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Galactose |
Inferred relationship |
Some |
|
Fecal galactose level (procedure) |
Component |
False |
Galactose |
Inferred relationship |
Some |
2 |
Galactose microparticles+palmitic acid 3996mg/4mg granules+diluent |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Galactose |
Inferred relationship |
Some |
|
Galactose microparticles+palmitic acid 2497.5mg/2.5mg granules+diluent |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Galactose |
Inferred relationship |
Some |
|
Product containing galactose (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Galactose |
Inferred relationship |
Some |
1 |
Product containing galactose and palmitic acid (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Galactose |
Inferred relationship |
Some |
1 |
Increase or decrease in galactose content of the diet. |
Direct substance |
True |
Galactose |
Inferred relationship |
Some |
1 |
Decreased galactose diet (regime/therapy) |
Direct substance |
True |
Galactose |
Inferred relationship |
Some |
1 |
Galactose microparticles+palmitic acid 2497.5mg/2.5mg granules |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Galactose |
Inferred relationship |
Some |
|
Galactose microparticles+palmitic acid 3996mg/4mg granules |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Galactose |
Inferred relationship |
Some |
|
Galactose 3.99 g and palmitic acid 4 mg powder for suspension for injection vial |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Galactose |
Inferred relationship |
Some |
1 |
Galactose 3.99 g and palmitic acid 4 mg powder for suspension for injection vial |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Galactose |
Inferred relationship |
Some |
1 |
Galactose 2.49 g and palmitic acid 2.5 mg powder for suspension for injection vial |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Galactose |
Inferred relationship |
Some |
1 |
Galactose 2.49 g and palmitic acid 2.5 mg powder for suspension for injection vial |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Galactose |
Inferred relationship |
Some |
1 |
Product containing galactose and palmitic acid in parenteral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Galactose |
Inferred relationship |
Some |
1 |
Galactose only product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Galactose |
Inferred relationship |
Some |
1 |
Galactose and palmitic acid only product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Galactose |
Inferred relationship |
Some |
1 |
Product containing only galactose and palmitic acid in parenteral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Galactose |
Inferred relationship |
Some |
1 |
Galactose intake |
This attribute specifies the resulting output of the process characterized by the observed feature. |
False |
Galactose |
Inferred relationship |
Some |
2 |
Increase in galactose content of the diet compared to the assessed baseline intake of galactose for the individual. |
Direct substance |
True |
Galactose |
Inferred relationship |
Some |
1 |
The known quantity of intake of galactose from all sources including food, beverages, breastmilk/formula, supplements, and via enteral and parenteral routes. |
This attribute specifies the resulting output of the process characterized by the observed feature. |
False |
Galactose |
Inferred relationship |
Some |
5 |
The approximate quantity of intake of galactose from all sources including food, beverages, breastmilk/formula, supplements, and via enteral and parenteral routes. |
This attribute specifies the resulting output of the process characterized by the observed feature. |
False |
Galactose |
Inferred relationship |
Some |
5 |
The approximate quantity of intake of galactose from all sources including food, beverages, breastmilk/formula, supplements, and via enteral and parenteral routes. |
This attribute specifies an entity that the process which the property characterizes specifically acts on. |
False |
Galactose |
Inferred relationship |
Some |
5 |
Galactose intake |
This attribute specifies an entity that the process which the property characterizes specifically acts on. |
False |
Galactose |
Inferred relationship |
Some |
2 |
The known quantity of intake of galactose from all sources including food, beverages, breastmilk/formula, supplements, and via enteral and parenteral routes. |
This attribute specifies an entity that the process which the property characterizes specifically acts on. |
False |
Galactose |
Inferred relationship |
Some |
5 |
Galactose intake |
This attribute specifies an entity that the process which the property characterizes specifically acts on. |
True |
Galactose |
Inferred relationship |
Some |
1 |
The approximate quantity of intake of galactose from all sources including food, beverages, breastmilk/formula, supplements, and via enteral and parenteral routes. |
This attribute specifies an entity that the process which the property characterizes specifically acts on. |
True |
Galactose |
Inferred relationship |
Some |
1 |
The known quantity of intake of galactose from all sources including food, beverages, breastmilk/formula, supplements, and via enteral and parenteral routes. |
This attribute specifies an entity that the process which the property characterizes specifically acts on. |
True |
Galactose |
Inferred relationship |
Some |
1 |
Fecal galactose level (procedure) |
Component |
True |
Galactose |
Inferred relationship |
Some |
1 |
Galactose measurement, urine |
Component |
True |
Galactose |
Inferred relationship |
Some |
1 |